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ABSTRACT
New 3,5-dimethyl-4-[(E)-4-(R1-phenyl)diazenyl]isoxazoles and 3,5-dimethyl-1-(R2-phenyl)-4-[(E)-(R1-phenyl)diazenyl]-1H-pyrazoles may be obtained by 
reaction of 3-[2-(R1-phenyl)hydrazono)]pentane-2,4-dione with H2NOH·HCl and R2-4-C6H4-NHNH2, respectively. The reactions were performed in ethanol as 
solvent and catalyzed by glacial acetic acid.
The biological activity of substituted isoxazoles and pyrazoles has been of 
interest in the last years, due to the versatility of their properties. In fact, several 
isoxazoles1-7 and pyrazoles8-22 have a remarkable importance in medicine and 
particularly pyrazole’s chemistry has been extended toward the catalysis23 and 
coordination chemistry24-25. On the other hand, it is well known that β-diketones 
as pentane-2,4-dione, CH2(COCH3)2, in basic medium, may couple with 
substituted diazonium salts26-27 yielding series of compounds that belong to the 
β-diketohydrazones family, namely 3-[2-(R1-phenyl)hydrazono)]pentane-2,4-
dione, see Schemes. In this work, we show that these compounds may be used 
as precursors for obtaining easily heterocycles series, namely isoxazole and 
pyrazole derivatives. 
Preliminary studies28-30 have shown that β-diketohydrazones, react with 
hydroxylamine hydrochloride (molar ratio 1:1 at reflux temperature for 18 h), 
using acetic acid as catalyst, in ethanol, affording in good yields (>70 %) 3,4,5-
trisubstituted isoxazoles, such as 3,5-dimethyl-4-[(E)-4-(R1-phenyl)diazenyl]
isoxazoles, Scheme 1. The solid compounds are often precipitated by addition 
of excess of water. After addition of water some of them yield insoluble oils 
due to the formation of an immiscible ethylacetate/water mixture. However, 
under vigorous stirring and cooling about 0 ºC, the corresponding solids are 
obtained.
In accord with Scheme 1, we propose that the reaction forms an oxime 
intermediate whose reactivity center, Z-β-ketooxime (I), under prolonged 
heating in HOAc medium, suffers an addition-displacement reaction affording 
the corresponding products.
Likewise, under similar conditions, Scheme 2, these β-diketohydrazones 
also react with monosubstituted arylhydrazines, R2-C6H4-NHNH2 (molar ratio 
1:1 under reflux temperature for 36 h), affording in good yields (>65 %) series 
of 1,3,4,5-tetrasubstituted pyrazoles, of the type 3,5-dimethyl-1-(R2-phenyl)-4-
[(E)-(R1-phenyl)diazenyl]-1H-pyrazoles. The corresponding pyrazoles may be 
isolated by similar procedures to those used for isoxazoles. 
In this case we believe that the reactivity center, Z-β-ketohydrazone (II), of 
the ketodihydrazone intermediate, Scheme 2, after protonation of the carbonyl 
group, also suffers an addition-displacement reaction to yield the corresponding 
pyrazoles. 
These series of compounds have been characterized using elemental 
analysis, gas-chromatography/mass-spectrometry and spectroscopic methods 
(UV-visible, IR, 1H NMR, 13C NMR). A typical two-dimensional HBMC 
spectrum of one member of the isoxazoles series, is shown in Figure 1. Besides, 
the crystalline and molecular structures of one isoxazole28 and two pyrazoles29-
30 have been recently authenticated by X-Ray diffraction analysis. Some 
additional synthetic details may be found in these previous reports28-30.
Additional studies on this subject, involving other β-diketone precursors, 
v. gr. CH2(COR1)(COR2), (R1= Ph, R2= Me, Ph), CH2(COCH3)(CO2Et) or 
CH2(CO2Et)2, are currently in progress whose results will be published at due 
time. Finally, the biological activity of isoxazoles will be evaluated as the 
following stage.
Figure 1: HBMC spectrum obtained in CDCl3 on a Bruker AC 200P 
Spectrometer (1H) (13C at 50.3 MHz, J mod. sequence 1H 200.1 MHz) using 
internal TMS.
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